Veccia, Antonello
 Distribuzione geografica
Continente #
NA - Nord America 290
AS - Asia 96
EU - Europa 90
Continente sconosciuto - Info sul continente non disponibili 48
SA - Sud America 4
AF - Africa 2
Totale 530
Nazione #
US - Stati Uniti d'America 267
IT - Italia 81
SG - Singapore 21
CA - Canada 20
CN - Cina 18
BD - Bangladesh 14
VN - Vietnam 14
HK - Hong Kong 12
KR - Corea 5
IN - India 4
SE - Svezia 3
AR - Argentina 2
FI - Finlandia 2
IQ - Iraq 2
BB - Barbados 1
BR - Brasile 1
CR - Costa Rica 1
DE - Germania 1
EC - Ecuador 1
EG - Egitto 1
FR - Francia 1
GB - Regno Unito 1
ID - Indonesia 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 482
Città #
Council Bluffs 43
Trento 36
Ashburn 24
San Jose 16
Singapore 15
Hong Kong 12
Phoenix 12
Santa Clara 12
Milan 10
Columbus 8
New York 8
Secaucus 6
Hanoi 5
Los Angeles 5
Riverside 5
Seoul 5
Toronto 4
Wuxi 4
Houston 3
Miano 3
Portland 3
Baghdad 2
Baltimore 2
Bari 2
Brandon 2
Brooklyn 2
Buffalo 2
Chicago 2
Cincinnati 2
Da Nang 2
Dallas 2
Florence 2
Helsinki 2
Ho Chi Minh City 2
Kyle 2
Louisville 2
Naples 2
North Bergen 2
Ogden 2
Peru 2
Rome 2
San Francisco 2
Sellersburg 2
Torbole Casaglia 2
Adel 1
Alexandria 1
Arezzo 1
Atlanta 1
Baton Rouge 1
Batu Ampar 1
Beijing 1
Bergedorf 1
Biella 1
Boardman 1
Bologna 1
Brentwood 1
Bridgetown 1
Burnaby 1
Casavatore 1
Castel Guelfo di Bologna 1
Charlotte 1
Chatham 1
Ciudad Nezahualcoyotl 1
Clintonville 1
Columbia 1
Coriano 1
Córdoba 1
Denver 1
Detroit 1
Elkridge 1
Evergreen Park 1
Fayetteville 1
Fort Wayne 1
Fredericton 1
Ft. Washington 1
Genoa 1
Giza 1
Henrico 1
Hyderabad 1
Istanbul 1
Jamul 1
Kanpur 1
Kenosha 1
Kingston 1
Lakewood 1
Largo 1
Las Vegas 1
Lawrenceville 1
Lucca 1
Lévis 1
Macerata 1
Manassas 1
Manteca 1
Maple Heights 1
Marble Falls 1
Mashpee 1
Mazzè 1
Medina 1
Meriden 1
Mesa 1
Totale 341
Nome #
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives 76
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC 48
Association of G8 screening tool with prognosis and survival in patients with non-small cell lung cancer: A retrospective analysis from a single institution 47
Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line 46
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide 45
Organized prostate cancer screening program: a proposal from the Italian Society of Urology (SIU) 36
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone 30
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer 26
Modified 3-week schedule of gemcitabine plus cisplatin for non-small cell lung cancer treatment 23
Prostate cancer: Screening and early detection 22
Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer 21
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 21
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial 20
Cardiovascular toxicities of systemic treatments of prostate cancer 20
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients 20
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone 17
Docetaxel rechallenge in patients with castration-resistant prostate cancer - A review 12
Totale 530
Categoria #
all - tutte 1.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026231 0 0 0 0 0 0 0 2 97 56 17 59
2026/2027299 32 39 96 129 3 0 0 0 0 0 0 0
Totale 530